|Articles|January 21, 2021
Operational Impact of Annex 1 Update
Author(s)Veltek Associates, Inc.
The update for EU annex 1 is more than a simple revision, solidifying the expectation that facility fully understand their processes and systems.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
CNPV Deep Dive: Perspectives on Accelerated FDA Review From the C-Suite to the Manufacturing Floor
2
Is Pharma Solving the Right Problem with its Data Transformation Efforts?
3
How Codexis is Redefining Pharma Biocatalysis
4
Multi-Compendial Compliance for Pharmaceutical Excipients–Part 1: A Practical Application of Specification Equivalence
5